| Literature DB >> 33171599 |
Miriam Latorre-Millán1,2, Azahara I Rupérez1,3, Esther M González-Gil1,4,5, Alba Santaliestra-Pasías1,3,4, Rocío Vázquez-Cobela6, Mercedes Gil-Campos4,7, Concepción M Aguilera4,5,8, Ángel Gil4,5,8, Luis A Moreno1,3,4, Rosaura Leis4,6,9, Gloria Bueno1,2,3,4.
Abstract
Diet is a key factor for obesity development; however, limited data are available on dietary cluster analysis in children with obesity. We aimed to assess the associations between dietary patterns and obesity and several cardiometabolic markers. Anthropometry, bioelectrical impedance, blood pressure and plasma biomarkers of oxidative stress, inflammation and endothelial damage were determined in 674 Caucasian children, aged 5-16, with normal or excess weight. Using a food frequency questionnaire and cluster analysis, two consistent dietary patterns were shown, labeled as health conscious (HC) and sweet and processed (SP). The HC pattern included a greater proportion of participants with overweight/obesity than the SP cluster (80.1% vs. 63.8%). However, children with obesity within the HC cluster, showed less abdominal fat, through waist to hip (0.93 vs. 0.94) and waist to height (0.61 vs. 0.63) indexes (p < 0.01). Univariate general models showed several additional differences in cardiometabolic risk biomarkers in the global and stratified analyses, with a healthier profile being observed mainly in the HC cluster. However, multivariate models questioned these findings and pointed out the need for further studies in this field. Anyhow, our findings support the benefits of a healthy diet and highlight the importance of dietary patterns in the cardiometabolic risk assessment of children with overweight/obesity, beyond weight control.Entities:
Keywords: anthropometry; cardiovascular disease; cluster analysis; diet; inflammation; obesity; oxidative stress
Mesh:
Substances:
Year: 2020 PMID: 33171599 PMCID: PMC7695147 DOI: 10.3390/nu12113424
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Descriptive characteristics of children and adolescents by body mass index (BMI) status (GENOBOX cohort).
| All | Normal Weight | Overweight and Obesity |
| |
|---|---|---|---|---|
| Gender |
| |||
| Male | 307 (45.5%) | 95 (53.4%) | 212 (42.7%) | |
| Female | 367 (54.5%) | 83 (46.6%) | 284 (57.3%) | |
| Pubertal stage (Tanner) | 0.163 | |||
| Prepubertal | 333 (49.4%) | 96 (53.9%) | 237 (47.8%) | |
| Pubertal | 341 (50.6%) | 82 (46.1%) | 259 (52.2%) | |
| Maternal education level |
| |||
| Low | 58 (8.9%) | 9 (5.2%) | 49 (10.3%) | |
| Medium | 480 (73.8%) | 116 (66.7%) | 364 (76.5%) | |
| High | 112 (17.2%) | 49 (28.2%) | 63 (13.2%) | |
| Age | 0.273 | |||
| Children (5–11 years) | 439 (65.1%) | 122 (68.5%) | 317 (63.9%) | |
| Adolescents (12–16 years) | 235 (304.9%) | 56 (31.5%) | 179 (36.1%) | |
| Age (years) Mean ± SD | 10.7 (2.5) | 10.5 (2.7) | 10.7 (2.5) | 0.297 |
| BMI |
| |||
| Normal weight | 178 (26.4%) | 178 (100%) | 0 (0%) | |
| Overweight | 165 (24.5%) | 0 (0%) | 165 (33.3%) | |
| Obesity | 331 (49.1%) | 0 (0%) | 331 (66.7%) | |
| BMI (kg/m2) Mean (SD) | 24.0 (5.6) | 17.3 (2.3) | 26.4 (4.3) |
|
| BMI | 1.8 (1.7) | −0.3 (0.6) | 2.6 (1.3) |
|
p: significance of the χ2 test for categorical variables and Student’s t test for continuous variables, assessing differences between normal weight and overweight/obese groups. Bold letters in p values mean significant differences between BMI subgroups. Abbreviations: BMI, body mass index; SD, standard deviation.
Figure 1Radar plot of the significant differences (p < 0.05) in food frequency questionnaire (FFQ) items that characterize each dietary pattern in Spanish children and adolescents.
Figure 2Frequency distribution of BMI subgroups in children and adolescents in each dietary cluster (GENOBOX cohort).
Descriptive characteristics of Spanish children and adolescents by dietary cluster (GENOBOX cohort).
| Health Conscious | Sweet and Processed |
| |
|---|---|---|---|
| Gender | 0.102 | ||
| Male | 175 (43.4%) | 132 (48.7%) | |
| Female | 228 (56.6%) | 139 (51.3%) | |
| Pubertal stage (Tanner) |
| ||
| Prepubertal | 184 (45.7%) | 149 (55.0%) | |
| Pubertal | 219 (54.3%) | 122 (45.0%) | |
| Maternal education level | 0.288 | ||
| Low | 29 (7.5%) | 29 (11.1%) | |
| Medium | 291 (75.0%) | 189 (72.1%) | |
| High | 68 (17.5%) | 44 (16.8%) | |
| Age |
| ||
| Children (5–11 years) | 245 (60.8%) | 194 (71.6%) | |
| Adolescents (12–16 years) | 158 (39.2%) | 77 (28.4%) | |
| Age (years) Mean (SD) | 10.9 (2.5) | 10.3 (2.5) | 0.002 |
| BMI |
| ||
| Normal weight | 80 (19.9%) | 98 (36.2%) | |
| Overweight | 117 (29.0%) | 48 (17.7%) | |
| Obesity | 206 (51.1%) | 125 (46.1%) |
p: significance of the χ2 test for categorical variables and Student’s t test for continuous variables, assessing differences between dietary clusters. Bold letters in p values mean significant differences between dietary clusters. Abbreviations: BMI, body mass index; SD, standard deviation.
Mean differences of cardiometabolic and health risk indicators between dietary clusters in the three BMI subgroups of children and adolescents (GENOBOX cohort).
| All ( | Normal Weight ( | Overweight ( | Obesity ( | |||||
|---|---|---|---|---|---|---|---|---|
| Health Conscious | Sweet and Processed | Health Conscious | Sweet and Processed | Health Conscious | Sweet and Processed | Health Conscious | Sweet and Processed | |
| ( | ( | ( | ( | ( | ( | ( | ( | |
| Age (years) |
|
| 10.8 (2.9) | 10.2 (2.5) |
|
| 10.5 (2.5) | 10.4 (2.6) |
| Body composition indicators | ||||||||
| BMI (kg/m2) | 24.6 (5.1) | 23.2 (6.3) | 17.7 (2.6) | 17.0 (2.0) |
|
| 27.7 (3.9) | 28.5 (4.4) |
| BMI | 2.0 (1.6) | 1.6 (1.9) | −0.21 (0.56) | −0.33 (0.54) |
|
| 3.11 (1.06) | 3.35 (1.18) |
| Body mass (kg) | 54.6 (18.5) | 49.5 (20.6 | 38.7 (14.0) | 34.3 (11.0) |
|
| 60.9 (19.2) | 62.8 (20.3) |
| Hip circumference (cm) |
|
| 76.5 (11.4) | 72.0 (9.5) |
|
| 95.5 (12.8) | 95.3 (13.7) |
| Waist circumference (cm) | 82.3 (15.0) | 77.1 (17.6) | 64.8 (11.8) | 60.8 (5.9) | 81.7 (9.7) | 75.4 (9.4) | 89.5 (12.6) | 91.3 (14.4) |
| Waist to hip index | 0.56 (0.08) | 0.54 (0.10) | 0.85 (0.08) | 0.85 (0.07) | 0.90 (0.08) | 0.90 (0.07) |
|
|
| Waist to height index | 83.7 (30.1) | 68.1 (35.7) | 0.45 (0.05) | 0.44 (0.04) | 0.54 (0.05) | 0.52 (0.04) |
|
|
| Skinfold sum (mm) |
|
| 42.1 (18.7) | 37.2 (17.3) | 88.4 (17.7) | 77.0 (22.1) | 102.4 (18.8) | 103.0 (22.6) |
| FMI | 11.6 (5.1) | 10.4 (5.6) | 3.5 (2.7) | 2.7 (1.8) | 6.4 (2.3) | 5.7 (2.4) | 9.7 (4.06) | 9.3 (4.0) |
| FFMI | 10.9 (2.5) | 10.3 (2.5) | 8.1(4.2) | 7.2 (3.9) | 11.6 (4.7) | 10.3 (4.1) | 13.6 (4.9) | 14.7(5.2) |
| Cardiometabolic indicators | ||||||||
| Blood pressure | ||||||||
| SBP (mm Hg) ^ | 109 (13) | 108 (14) | 104 (12) | 100 (12) | 108 (12) | 106 (13) | 112 (14) | 121 |
| DBP (mm Hg) ^ |
|
|
|
| 64 (11) | 63 (8) | 67 (11) | 121 |
| General metabolic biomarkers | ||||||||
| Glucose (mg/dL) | 84 (8) | 86 (8) | 84 (8) | 86 (7) | 85 (8) | 88 (8) | 84 (8) | 85 (8) |
| Insulin (mU/L) | 12.20 (8.42) | 11.52 (9.92) | 8.00 (4.54) | 7.27 (4.87) | 11.11 (7.78) | 10.55 (6.12) | 14.47 (9.18) | 15.4 (12.44) |
| HOMA-IR | 2.57 (1.84) | 2.48 (2.18) | 1.68 (1.00) | 1.56 (1.08) | 2.35 (1.73) | 2.36 (1.53) | 3.05 (2.00) | 3.27 (2.70) |
| TG (mg/dL) | 69 (34) | 69(35) | 57(23) | 54 (23) | 66 (30) | 77 (44) | 76(38) | 77 (34) |
| Cholesterol (mg/dL) | 165 (30) | 161 (28) | 169 (26) | 164 (28) | 166 (33) | 163 (31) | 162 (30) | 159 (26) |
| LDLc (mg/dL) | 97 (26) | 92 (25) | 95 (22) | 87 (26) | 99 (30) | 93 (25) | 97 (26) | 94 (24) |
| HDLc (mg/dL) ^ | 50 (13) | 55 (15) | 59 (13) | 65 (15) | 49 (11) | 54 (14) | 47 (12) | 47 (11) |
| HDLc/LDLc index | 0.61 (0.46) | 0.81 (0.67) |
|
| 0.59 (0.43) | 0.78 (0.65) | 0.6 (0.54) | 0.72 (0.73) |
| AST (U/L) | 22 (9) | 23 (7) | 24 (8) | 25 (6) |
|
| 22 (10) | 22 (7) |
| ALT (U/L) | 20 (12) | 19 (11) | 17 (9) | 16 (6) | 18 (9) | 21 (21) | 22 (14) | 20 (8) |
| GGT (U/L) | 12 (7) | 13 (7) | 10 (3) | 10 (3) |
|
| 14 (9) | 15 (5) |
| Oxidative stress biomarkers | ||||||||
| Carotenes/TG |
|
| 2.70 (2.32) | 2.55 (1.56) | 1.43 (1.12) | 1.34 (0.81) | 1.38 (1.36) | 1.00 (0.76) |
| Tocopherols/TG | 0.14 (0.07) | 0.15 (0.07) | 0.17 (0.07) | 0.19 (0.07) | 0.13 (0.06) | 0.12 (0.06) | 0.13 (0.08) | 0.13 (0.05) |
| TAC (mM Eq Trolox®) | 2.05 (0.87) | 2.09 (0.91) | 1.88 (0.66) | 1.99 (0.75) | 2.06 (0.85) | 2.19 (1.13) | 2.11 (0.97) | 2.17 (0.96) |
| Catalase (U/g Hb) |
|
| 119.65 (71.23) | 136.22 (119.74) |
|
| 180.90 (118.02) | 162.27 (74.02) |
| Adipokines and biomarkers of inflammation and endothelial damage | ||||||||
| Adiponectin (mg/L) | 14.58 (8.67) | 15.18 (8.31) | 17.27 (11.37) | 17.08 (9.52) | 14.91 (7.86) | 14.51 (8.86) | 13.13 (7.31) | 13.51 (6.05) |
| Leptin (ug/L) |
|
| 4.59 (4.89) | 3.95 (4.26) | 12.44 (5.83) | 12.47 (9.57) | 22.47 (14.32) | 25.13 (18.36) |
| Resistin (ug/L) ^ |
|
| 24.07 (21.24) | 23.85 (17.18) | 18.43 (10.37) | 18.80 (14.73) | 19.4 (13.27) | 19.24 (10.32) |
| TNFα (ng/L) ^ |
|
| 2.27 (1.20) | 2.4 (1.34) | 2.67 (2.11) | 3.26 (1.95) | 3.15 (1.59) | 3.23 (1.48) |
| MCP-1 (ng/L) |
|
| 83.54 (28.28) | 85.21 (39.62) | 88.01 (48.11) | 89.70 (32.51) |
|
|
| tPAI-1 (ug/L) |
|
| 16.31 (12.21) | 17.8 (12.94) |
|
| 26.61 (14.93) | 31.92 (18.34) |
| Selectin (ug/L) ^ | 27.34 (14.7) | 30.38 (16.59) | 27.86 (15.66) | 24.51 (11.69) |
|
| 31.06 (15.25) | 33.6 (17.38) |
| sVCAM-1 (mg/L) ^ |
|
| 1.07 (0.33) | 1.20 (0.27) | 1.00 (0.27) | 1.15 (0.28) | 1.04 (0.34) | 1.07 (0.22) |
| MPO (ug/L) |
|
| 42.25 (77.48) | 36.98 (50.22) | 27.96 (29.79) | 29.97 (39.36) | 46.15 (105.63) | 30.18 (33.95) |
^ Logarithm transformed variable used for analyses. Bold letters mean significant differences (*: p ≤ 0.05; **: p ≤ 0.01; ***: p ≤ 0.001) between dietary patterns in the stepwise generalized linear models adjusted for recruitment center, sport practice, pubertal stage, gender and, additionally, maternal education level for body composition or BMI Z-score for metabolic variables. Student’s t-test was used to analyze age differences. Abbreviations: BMI: body mass index; circ.: circumference; FMI: fat mass index; FFMI, free fat mass index: SBP: systolic blood pressure; DBP: diastolic blood pressure; HOMA-IR: homeostatic model assessment for insulin resistance; TG: triglycerides, HDLc: high-density lipoprotein cholesterol; LDLc: low-density lipoprotein cholesterol; AST: aspartate transaminase; ALT: alanine transaminase; GGT: gamma-glutamyl transferase; TAC: total antioxidant capacity; TNFα: tumor necrosis factor alpha; MCP-1: monocyte chemoattractant protein-1; tPAI-1: total plasminogen activator inhibitor-1; sVCAM1: soluble vascular cell adhesion molecule-1; MPO: myeloperoxidase.